Channels - Baseline Nutritional Indices as Prognostic Indicators in Patients with Recurrent or Metastatic Nasopharyngeal Carcinoma Treated with the PD-L1 Inhibitor KL-A167: A Secondary Analysis of the KL-A167 Trial

Similar Items: Baseline Nutritional Indices as Prognostic Indicators in Patients with Recurrent or Metastatic Nasopharyngeal Carcinoma Treated with the PD-L1 Inhibitor KL-A167: A Secondary Analysis of the KL-A167 Trial

Quick Look
Re: predictive modeling of treatment-related thyroid dysfunction and prognostic implication in advanced nasopharyngeal carcinoma with PD-1 inhibitors
Quick Look
The Prognostic Value of Serum Inflammatory Markers in Nasopharyngeal Carcinoma Patients Treated With Immune Checkpoint Inhibitors: A Multicenter Study
Quick Look
The prognostic value of baseline hematological parameters of peripheral blood in metastatic gastric cancer treated with apatinib
Quick Look
Refining the boundaries of the nodal CTV in the middle neck for nasopharyngeal carcinoma
Quick Look
Biomarker‐based long‐term safety and efficacy of PD‐1/PD‐L1 inhibitors combined with chemotherapy in advanced gastroesophageal carcinomas: A systematic review and meta‐analysis
Quick Look
Association Between Blood Transfusion and Survival Outcomes in Metastatic Cutaneous Melanoma Treated with Nivolumab
Quick Look
Long-term complete response of metastatic adrenocortical carcinoma using streptozotocin-based therapy
Quick Look
KL-Metamatic Ghost Ship
Quick Look
Revised tumor burden score for prognostic stratification in metastatic colorectal cancer patients receiving immunotherapy: a retrospective study
Quick Look
Interactions between hematological biomarkers of virus infection and immune cells in mediating distant metastasis in nasopharyngeal carcinoma: insights into prognosis and induction chemotherapy administration
Quick Look
TTK Overexpression: A Negative Prognostic Biomarker in Anaplastic Thyroid Carcinoma
Quick Look
Correction to: Survivorship in advanced ovarian cancer: a prognostic model for overall survival and risk of recurrence
Quick Look
Oncolytic virus and PD-1/PD-L1 blockade combination therapy
Quick Look
Treating renal cell carcinoma in young adults: challenges and solutions
Quick Look
Prognostic and therapeutic roles of specific genotypes through target-gene sequencing on gastroenteropancreatic neuroendocrine carcinoma
Quick Look
Treatment outcomes of Epstein-Barr virus associated nasopharyngeal carcinoma with three-dimensional conformal radiotherapy: A retrospective review
Quick Look
Tumor B‐cell infiltration in platinum‐treated advanced muscle‐invasive urothelial carcinoma
Quick Look
Prognostic and Predict Value of Peripheral Blood Circulating Tumor Cells Programmed Death‐Ligand 1 Expression and F‐18‐Fluorodeoxyglucose Metabolic Parameters in Patients With Advanced Non‐Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors
Quick Look
Real-World Outcomes Among Medicare Beneficiaries Treated with Bruton Tyrosine Kinase Inhibitors for Treatment-Naïve CLL
Quick Look
Capecitabine versus Paclitaxel After CDK4/6 Inhibitor Progression in Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer: A Real-World Study
Quick Look
Revisiting Thoracic Duct Resection in Esophageal Squamous Cell Carcinoma: A Propensity‐Matched Analysis and Immunologic Insight Into Recurrence Risk
Quick Look
Maintenance Metronomic Chemotherapy in Treatment of Metastatic Colorectal Cancer
Quick Look
Prognostic Impact of the Systemic Immune-Inflammation Index in Unresectable Hepatocellular Carcinoma Undergoing Second-Line Combination Therapy: A Multicenter Study
Quick Look
ATA 2015-2025 risk stratification transition: prognostic significance of N1b disease in papillary thyroid carcinoma with limited nodal burden